Subcutaneous Biologic Drugs and Affiliated Technologies Market is projected to be worth over USD 180 billion by 2030

Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration. Further, many existing drug delivery devices, including prefilled syringes, pen injectors, auto injectors, needle-free injectors and large volume wearable injectors, have been / are being designed for subcutaneous administration of biologics.

The USD 180+ billion (by 2030) financial opportunity associated with subcutaneous biologics, affiliated drug delivery systems and subcutaneous formulation technology licensing deals, has been analyzed across the following segments:

Subcutaneous Biologic Drugs and Affiliated Technologies Market, Trends by 2030

Market Segment:  

Phase of development

  • Approved
  • Pre-registration & Phase III
  • Phase II & Phase II/III

Type of molecule

  • Cell and gene therapies
  • Monoclonal antibodies
  • Proteins
  • Peptides (recombinant)
  • Vaccines
  • Others

Target therapeutic area

  • Autoimmune disorders
  • Blood disorders
  • Bone disorders
  • Genetic disorders
  • Metabolic disorders
  • Neurological disorders
  • Oncological disorders
  • Respiratory disorders
  • Others

Type of drug delivery system

  • Large volume wearable injectors
  • Autoinjectors
  • Prefilled syringes
  • Needle-free injectors
  • Drug reconstitution systems
  • Revenues from licensing deals
  • Upfront payments
  • Milestone payments

Key geographical regions

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

The Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 report features the following companies, which we identified to be key players in this domain:

Market Key Players:

  • Adocia
  • Ajinomoto Bio-Pharma Services
  • Arecor
  • Alteogen
  • Ascendis Pharma
  • Avadel Pharmaceuticals
  • Camurus
  • Creative BioMart
  • Creative Biolabs
  • DURECT
  • Eagle Pharmaceuticals
  • Halozyme Therapeutics
  • MedinCell
  • Xeris Pharmaceuticals
  • Serina Therapeutics

Request for PDF Sample: https://www.rootsanalysis.com/reports/314/request-sample.html

Table of Contents

1.       Preface

2.       Executive Summary

3.       Introduction

4.       Subcutaneous Biologics: Current Market Landscape

5.       Case Study: Leading Subcutaneous Biologics

6.       Subcutaneous Formulation Technologies: Current Market Landscape

7.       Subcutaneous Formulation Technology Developers: Company Competitiveness Analysis

8.       Subcutaneous Formulation Technology Developers: Company Profiles

9.       Partnerships and Collaborations

10.     Subcutaneous Drug Delivery Systems: Current Market Landscape

11.     Swot Analysis

12.     Market Forecast and Opportunity Analysis

13.     Concluding Remarks

14.     Executive Insights

15.     Appendix 1:  Tabulated Data

16.     Appendix 2: List Of Companies And Organization

For Customization: https://www.rootsanalysis.com/reports/314/request-customization.html

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]



Source : NewsOnFloor

Related Articles

Leave a Comment